At a glance
- Originator Meiji Seika Kaisha
- Class Antibacterials; Antivirals
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Bacterial infections
Most Recent Events
- 18 Oct 1994 Discontinued-Preclinical for Bacterial infections in Japan (Unknown route)